Genus plc
General ticker "GENSF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.8B (TTM average)
Genus plc follows the US Stock Market performance with the rate: 41.2%.
Estimated limits based on current volatility of 0.0%: low 35.15$, high 35.15$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-11-07, amount 0.29$ (Y1.65%)
Short-term GENSF quotes
Long-term GENSF plot
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | £593.40MM | £689.70MM | £668.80MM |
| Operating Expenses | £536.80MM | £649.20MM | £662.40MM |
| Operating Income | £56.60MM | £40.50MM | £6.40MM |
| Non-Operating Income | £-8.20MM | £-1.10MM | £-0.90MM |
| Interest Expense | £6.20MM | £14.30MM | £21.30MM |
| R&D Expense | £72.90MM | £93.30MM | £27.80MM |
| Income(Loss) | £48.40MM | £39.40MM | £5.50MM |
| Taxes | £11.70MM | £16.60MM | £3.10MM |
| Profit(Loss)* | £40.90MM | £33.30MM | £7.90MM |
| Stockholders Equity | £578.50MM | £569.40MM | £548.20MM |
| Inventory | £84.00MM | £85.10MM | £89.40MM |
| Assets | £1,017.90MM | £1,007.50MM | £1,028.90MM |
| Operating Cash Flow | £34.30MM | £50.40MM | £29.80MM |
| Capital expenditure | £42.10MM | £35.20MM | £24.70MM |
| Investing Cash Flow | £-67.20MM | £-30.90MM | £-19.30MM |
| Financing Cash Flow | £21.90MM | £-18.20MM | £-2.80MM |
| Earnings Per Share** | £0.63 | £0.51 | £0.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.